Advancing Clinical Pharmacology through Microgravity: Insights and Framework from Space-Based Research Programs

Abstract ID 128984 Poster Board 061 Introduction: The vastness of space offers an unparalleled laboratory for clinical pharmacology research, providing unique conditions to conduct drug discovery programs, clinical research initiatives, and trials in ways not possible on Earth. Recognizing the potential of microgravity to revolutionize our understanding and treatment of diseases, this paper reviews a series of case-based clinical research studies, drug discovery initiatives, and clinical trials conducted in the unique environment of space. Through this review, I aim to consolidate these findings to inform research professionals, address observed challenges and risks, and propose a comprehensive framework, the SAFE SpaceRF (Safe and Efficient Space Clinical Research Framework), designed to enable effective and safe clinical pharmacology programs in space. This endeavor seeks to accelerate the outcomes for clinical research initiatives on Earth, leveraging the unique aspects of microgravity to foster groundbreaking advancements in pharmacology and healthcare. Methodology: My approach involved a thorough review of space-based clinical research studies conducted to date, including but not limited to, the NASA Twin Study, investigations by the Institute of Cancer Research London, the KRAS Protein Crystallization study aboard the International Space Station (ISS), and various others focusing on the behavior of cells and molecules in microgravity. These studies provided invaluable insights into the potential of space as a novel setting for advancing clinical pharmacology, particularly in the realms of cancer research, cardiomyocyte development, and protein crystallization, among others. Case Studies and Insights: KRAS Protein Crystallization w/ Microgravity - Oncology Research Cancer Cell Behavior: The use of microgravity to study diffuse midline glioma (DMG) Cardiomyocyte Development: Stem Cell Growth in Microgravity Enhanced Regenerative Capabilities of Cancer Cells: Investigating the accelerated growth of cancer stem cells in microgravity, focusing on the activation of the ADAR1 enzyme, and its implications for cancer treatment. Challenges Addressed: The review identified several challenges in conducting space-based clinical pharmacology research and proposes framework to address those. Framework Proposed - SAFE SpaceRF: In response to these challenges, I would like to propose the SAFE SpaceRF, a framework built on twelve pillars designed to address the logistical, technical, and ethical challenges of conducting clinical pharmacology research projects in space. The framework incorporates strategic planning, advanced robotics, AI for data analysis and monitoring, radiation shielding technologies, comprehensive governance, ethical considerations, and international collaborations. SAFE SpaceRF aims to leverage the unique conditions of microgravity to enhance drug discovery and clinical trials, providing a structured approach to overcome the obstacles faced in space-based research. Conclusion: By providing a structured framework to navigate the challenges of space-based research, SAFE SpaceRF facilitates the safe and efficient conduct of clinical studies, aiming to accelerate medical advancements on Earth. Conflict of Interest Statement: None to declare.